BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14613374)

  • 1. Quality of Health Economic Studies (QHES)--tool or mask?
    Curtiss FR
    J Manag Care Pharm; 2003; 9(1):93. PubMed ID: 14613374
    [No Abstract]   [Full Text] [Related]  

  • 2. Harvey A. K. Whitney Lecture. Pharmacy and the complexity of health care.
    Mehl B
    Am J Health Syst Pharm; 2001 Aug; 58(16):1507-11. PubMed ID: 11515347
    [No Abstract]   [Full Text] [Related]  

  • 3. Quo vademus? A review of the regulatory environment.
    Huss H; Hutchison R
    Qual Assur; 1995 Sep; 4(3):181-6. PubMed ID: 8705113
    [No Abstract]   [Full Text] [Related]  

  • 4. PharmacoEconomics. Foreword.
    Milne CP
    Pharmacoeconomics; 2006 Dec; 24 Suppl 2():1-3. PubMed ID: 23389483
    [No Abstract]   [Full Text] [Related]  

  • 5. Examining the value and quality of health economic analyses: implications of utilizing the QHES.
    Ofman JJ; Sullivan SD; Neumann PJ; Chiou CF; Henning JM; Wade SW; Hay JW
    J Manag Care Pharm; 2003; 9(1):53-61. PubMed ID: 14613362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. e-Health in Europe.
    Mobach M
    Pharm World Sci; 2004 Feb; 26(1):1-2. PubMed ID: 15018249
    [No Abstract]   [Full Text] [Related]  

  • 7. Building the business case for quality improvement.
    Webber A
    J Am Pharm Assoc (2003); 2005; 45(4):437-42. PubMed ID: 16128498
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacoeconomics - Challenges for Health Professionals].
    Turčić P; Benković V; Brborović O; Valent A
    Acta Med Croatica; 2016 Apr; 70(2):117-23. PubMed ID: 28722840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary quality scores for pharmacoeconomic studies: balancing validity with need.
    Shaya FT
    J Manag Care Pharm; 2003; 9(1):87-8. PubMed ID: 14613369
    [No Abstract]   [Full Text] [Related]  

  • 10. Health care 2000: top 10 trends for the new century.
    Coile RC
    Russ Coiles Health Trends; 2000 Jan; 12(3):1, 4-12. PubMed ID: 10747683
    [No Abstract]   [Full Text] [Related]  

  • 11. Total cost of care: a discipline that leads to better care.
    Moore LG; DeBuono B
    J Ambul Care Manage; 2013; 36(3):193-8. PubMed ID: 23748266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective.
    Thwaites R; Townsend RJ
    Pharmacoeconomics; 1998 Feb; 13(2):175-80. PubMed ID: 10178645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the health care system the next victim of the financial crisis?
    Frezza EE; Wachtel MS
    Surg Laparosc Endosc Percutan Tech; 2009 Jun; 19(3):276. PubMed ID: 19542862
    [No Abstract]   [Full Text] [Related]  

  • 14. At the crossroads of quality.
    James B
    Hosp Health Netw; 2005 Jul; 79(7):142. PubMed ID: 16128326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Health economics: should it concern the health sector?].
    Collazo Herrera M; Cárdenas Rodríguez J; González López R; Miyar Abreu R; Gálvez González AM; Cosme Casulo J
    Rev Panam Salud Publica; 2002 Nov; 12(5):359-65. PubMed ID: 12587229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of future costs in health economic analysis publications: current situation and recommendations for the future.
    Gros B; Soto Álvarez J; Ángel Casado M
    Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):465-9. PubMed ID: 25737028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health care 1992: top 10 trends for the health field.
    Coile RC
    Hosp Strategy Rep; 1992 Jan; 4(3):1-8. PubMed ID: 10116314
    [No Abstract]   [Full Text] [Related]  

  • 18. Future of health care delivery in the United States?
    Alexander E
    Surg Neurol; 1988 May; 29(5):418-9. PubMed ID: 3363481
    [No Abstract]   [Full Text] [Related]  

  • 19. Interpreting the standard of care.
    Cavallerano AA
    J Am Optom Assoc; 1998 Mar; 69(3):141-2. PubMed ID: 9553328
    [No Abstract]   [Full Text] [Related]  

  • 20. NICE to advise firms on how to speed up NHS adoption of their drugs.
    Hawkes N
    BMJ; 2015 May; 350():h2813. PubMed ID: 26002040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.